CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

How Cloudbased Lims Helps Cros

How Cloudbased Lims Helps Cros

MMS Holdings Announces New Pro-Bono Support Program

MMS Holdings Announces New Pro-Bono...

Syneos Health and Science 37 Announce Strategic Partnership

Syneos Health and Science 37 Announce...

Inotiv Secures MilliporeSigmas BioReliance Genetic Toxicology Assets

Inotiv Secures MilliporeSigmas...

Avance Appoints New Business Development Manager APAC

Avance Appoints New Business...

The Growing Demand for Contract Research Organizations

The Growing Demand for Contract...

The Potential for Artificial Intelligence in Clinical Trials

The Potential for Artificial...

Craig Lipset Joins Member and Executive Advisor of MedVector

Craig Lipset Joins Member and...

How Cloudbased Lims Helps Cros

How Cloudbased Lims Helps Cros

MMS Holdings Announces New Pro-Bono Support Program

MMS Holdings Announces New Pro-Bono...

Syneos Health and Science 37 Announce Strategic Partnership

Syneos Health and Science 37 Announce...

Inotiv Secures MilliporeSigmas BioReliance Genetic Toxicology Assets

Inotiv Secures MilliporeSigmas...

Avance Appoints New Business Development Manager APAC

Avance Appoints New Business...

The Growing Demand for Contract Research Organizations

The Growing Demand for Contract...

The Potential for Artificial Intelligence in Clinical Trials

The Potential for Artificial...

Craig Lipset Joins Member and Executive Advisor of MedVector

Craig Lipset Joins Member and...

Genovac Appoints Pete Leland as its VP of Production and Characterization

Life Sciences Review Life Sciences Review | Thursday, May 20, 2021
Tweet

Leland joins Genovac as Vice President of production and characterization.


FREMONT, CA: Pete Leland, a 20-year veteran of the biotechnology sector, joins Genovac Antibody Discovery, Fargo, N.D., as its Vice President of production and characterization.


Genovac is a contract research firm that discovers and develops antibodies for therapeutic, diagnostic, and research markets. The company's core technologies, genetic immunization, advanced hybridoma, and single B cell screening allow rapid antibody discovery against biopharma's most challenging targets. With the appointment of Leland, Genovac can now offer its clients robust production and characterization services.


Pete is an accomplished and recognized pioneer in biotechnology. Genovac is committed to being a one-stop-shop, offering antibody discovery, production, and characterization services. With Pete's expertise and experience, the company has hit the ground running in the United States. Genovac is lucky to have him at the head of a critical part of its scientific team. 


Leland heads the group that manufactures and tests antibodies, which Genovac customers use to develop drugs that help fight genetic and infectious diseases like Covid-19, cancer, and neurological disorders.


Genovac is doing cutting-edge work helping pharmaceutical and diagnostic firms across the world. It is very exciting to establish these technologies at the Fargo site while offering scientific career opportunities in the process. Before joining Genovac, Leland was a principal scientist for downstream process development at Catalent, Madison, Wis. Before that, and he was a manager at Patheon, a division of Thermos Fisher Scientific, and the senior manager of technical operations in the Madison, Wis., Protein Division of Fargo-based Aldevron.  Leland has a Bachelor of Arts in chemistry from St. Olaf College, Northfield, Minn., and a doctorate in biochemistry from the University of Wisconsin-Madison.


Genovac Antibody Discovery has completed more than 3,500 projects, delivering antibodies to clients in North America, Australia, Europe, and Asia developed into commercial drugs. Genovac has completed about 25 client and internal COVID-19 campaigns and has developed two antibodies that neutralize the U.K., Brazilian, and South African mutations.


Weekly Brief

loading
Top 10 CROs - 2021
> <
  • DNA Sequencing 2022

    Top Vendors

    Current Issue
  • BioTech Startups 2022

    Top Vendors

    Current Issue
  • DNA Sequencing 2022

    Top Vendors

    Current Issue
  • BioTech Startups 2022

    Top Vendors

    Current Issue

Read Also

Role of Predictive Genomics in Sustainable Healthcare

Role of Predictive Genomics in Sustainable Healthcare

A Conversational AI Approach to Regulatory Intelligence

A Conversational AI Approach to Regulatory Intelligence

A rise in DNA Sequencing Market is expected in coming years

A rise in DNA Sequencing Market is expected in coming years

Omniabio Inc. Announces Private Investor

Omniabio Inc. Announces Private Investor
Data analysis for next-generation sequencing worth USD1.2 billion by 2026 - Cloud-based platforms emerging as preferred solutions

Data analysis for next-generation sequencing worth USD1.2 billion by 2026 - Cloud-based platforms emerging as preferred solutions

Lithuania's Vision to Become a Biotech Hub in Europe

Lithuania's Vision to Become a Biotech Hub in Europe

Bridging the Diversity Gap in Genomics

Bridging the Diversity Gap in Genomics

How does Biotechnology Provide Solutions to Human Needs?

How does Biotechnology Provide Solutions to Human Needs?
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/genovac-appoints-pete-leland-as-its-vp-of-production-and-characterization-nwid-369.html